Thomas B. Neff
2019
In 2019, Thomas B. Neff earned a total compensation of $11.4M as Chief Executive Officer at FibroGen, a 24% increase compared to previous year.
Compensation breakdown
| Option Awards | $5,333,469 |
|---|---|
| Salary | $687,115 |
| Stock Awards | $5,366,088 |
| Other | $20,800 |
| Total | $11,407,472 |
Neff received $5.4M in stock awards, accounting for 47% of the total pay in 2019.
Neff also received $5.3M in option awards, $687.1K in salary and $20.8K in other compensation.
Rankings
In 2019, Thomas B. Neff's compensation ranked 591st out of 13,971 executives tracked by ExecPay. In other words, Neff earned more than 95.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 591 out of 13,971 | 96th |
Division Manufacturing | 213 out of 5,695 | 96th |
Major group Chemicals And Allied Products | 56 out of 2,194 | 97th |
Industry group Drugs | 46 out of 1,880 | 98th |
Industry Pharmaceutical Preparations | 39 out of 1,392 | 97th |
Source: SEC filing on April 23, 2020.
Neff's colleagues
We found five more compensation records of executives who worked with Thomas B. Neff at FibroGen in 2019.
2019
K Yu
FibroGen
Chief Medical Officer
2019
James Schoeneck
FibroGen
Chief Executive Officer
2019
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
2019
Christine Chung
FibroGen
Senior Vice President, China Operations
2019
Pat Cotroneo
FibroGen